KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) EPS (Weighted Average and Diluted) (2016 - 2026)

Cme has reported EPS (Weighted Average and Diluted) over the past 18 years, most recently at $3.18 for Q1 2026.

  • Quarterly EPS (Weighted Average and Diluted) rose 21.37% to $3.18 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.72 through Mar 2026, up 17.91% year-over-year, with the annual reading at $11.16 for FY2025, 15.41% up from the prior year.
  • EPS (Weighted Average and Diluted) was $3.18 for Q1 2026 at Cme, down from $3.24 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $3.24 in Q4 2025 and troughed at $1.76 in Q4 2022.
  • The 5-year median for EPS (Weighted Average and Diluted) is $2.4 (2024), against an average of $2.37.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): decreased 27.52% in 2022 and later surged 35.0% in 2025.
  • Tracing CME's EPS (Weighted Average and Diluted) over 5 years: stood at $1.76 in 2022, then grew by 27.27% to $2.24 in 2023, then grew by 7.14% to $2.4 in 2024, then surged by 35.0% to $3.24 in 2025, then dropped by 1.85% to $3.18 in 2026.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $3.18, $3.24, and $2.49 for Q1 2026, Q4 2025, and Q3 2025 respectively.